"We need to move fast ... Europe (does not) lack ideas, it's an issue of implementation," said German Merck Group's CEO Belen Garijo, adding, however, that the catalyst for increasing competition ...

"We need to move fast ... Europe (does not) lack ideas, it's an issue of implementation," said German Merck Group's CEO Belen Garijo, adding, however, that the catalyst for increasing competition ...

Investors in Merck & Co Inc (Symbol: MRK) saw new options become available today, for the March 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRK ...

Germany’s Merck KGaA has joined with UK-based Artios Pharma ... tissue - a concept scientists term "synthetic lethality". German Merck said it plans to work with Artios, a DNA damage response ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver Leave Benefit as an additional family ...

German Chancellor Olaf Scholz said on Tuesday he does not support freedom of speech when it is used for extreme-right views, a day after a hand gesture by US billionaire Elon Musk caused uproar ...

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the introduction of a Caregiver Leave Benefit as an additional family-friendly offering for employees of ...

Belén Garijo, CEO of Merck KGaA, weighs in on Europe's competitiveness and the pharma giant's preparations for the impact of potential U.S. trade tariffs. Trump blames 'diversity' for deadly ...

Jan 22 (Reuters) - Robert F. Kennedy Jr. would retain legal fees earned from litigation against drugmaker Merck if he is confirmed as President Donald Trump's secretary of the U.S. Department of ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

Merck's robust Phase 3 pipeline, strong financials, and sustainable dividend make it a compelling investment despite risks like Medicare negotiations and patent expirations. Merck also appears to ...